European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure
NCT00696631
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
653
Enrollment
INDUSTRY
Sponsor class
Stopped
Terminated as the active treatment was associated with an increased hazard
Conditions
Congestive Heart Failure
Interventions
DRUG:
Dronedarone (SR33589)
DRUG:
Placebo
Sponsor
Sanofi